CFD merupakan instrumen yang rumit dan memiliki risiko tinggi kehilangan uang secara cepat karena adanya pengaruh leverage. 84% akun investor ritel mengalami kerugian saat melakukan kegiatan perdagangan CFD dengan penyedia ini. Anda harus mempertimbangkan apakah Anda memahami cara kerja CFD dan apakah Anda mampu menerima risiko tinggi kehilangan uang.

Scan to Download iOS&Android APP

Perdagangan Axsome Therapeutics, Inc. - AXSM CFD

-
0%
  • Summary
  • Historical Data
  • Events
  • Income Statement
  • Balance Sheet
  • Cash Flow
  • Ownership
Trading Conditions
Spread -
Biaya inap posisi Long

Long position overnight fee


Margin. Your investment $1,000.00
Biaya Overnight -0.030779 %
Charges from borrowed part ($-1.23)
Trade size with leverage ~ $5,000.00
Money from leverage ~ $4,000.00

Kunjungi platform
-0.030779%
Biaya inap posisi short

Short position overnight fee


Margin. Your investment $1,000.00
Biaya Overnight -0.013666 %
Charges from borrowed part ($-0.55)
Trade size with leverage ~ $5,000.00
Money from leverage ~ $4,000.00

Kunjungi platform
-0.013666%
Waktu biaya inap 22:00 (UTC)
Kuantitas min. yang diperdagangkan 1
Mata uang USD
Margin 20%
Bursa efek United States of America
Komisi perdagangan 0%

*Information provided by Capital.com

Key Stats
Prev. Close* N/A
Open* N/A
1-Year Change* N/A
Day's Range* N/A
52 wk Range 20.63-82.00
Average Volume (10 days) 926.31K
Average Volume (3 months) 25.81M
Market Cap 2.84B
P/E Ratio -100.00K
Shares Outstanding 43.43M
Revenue 25.67M
EPS -4.07
Dividend (Yield %) N/A
Beta 1.92
Next Earnings Date Feb 27, 2023

All data is provided by Refinitiv, except for data marked with an asterisk, which is *data provided by Capital.com

  • Last Week
  • Last Month
  • Last Year
  • Last two Years
  • Max
  • Daily
  • Weekly
  • Monthly
Date Close Change Change (%) Open High Low

Axsome Therapeutics, Inc. Events

Time (UTC) Country Event
No events scheduled
View all events
  • Annual
  • Quarterly
2016 2017 2018 2019 2020 2021
Total revenue 0 0 0 0 0 0
Total Operating Expense 27.5435 27.1643 32.8466 67.2451 100.388 124.707
Selling/General/Admin. Expenses, Total 6.34365 7.20669 9.35152 13.598 28.8967 66.6462
Research & Development 21.1999 19.9576 23.4951 53.6471 70.2446 58.0607
Unusual Expense (Income) 0 0 1.24701 0
Operating Income -27.5435 -27.1643 -32.8466 -67.2451 -100.388 -124.707
Interest Income (Expense), Net Non-Operating -0.13242 -1.9862 1.66369 -1.23954 -2.56584 -5.69606
Other, Net 0.47428 0.20711 0.21742 0.13945 0.05358 0
Net Income Before Taxes -27.2017 -28.9434 -30.9655 -68.3452 -102.901 -130.403
Net Income After Taxes -27.2017 -28.9434 -30.9655 -68.3452 -102.901 -130.403
Net Income Before Extra. Items -27.2017 -28.9434 -30.9655 -68.3452 -102.901 -130.403
Net Income -27.2017 -28.9434 -30.9655 -68.3452 -102.901 -130.403
Income Available to Common Excl. Extra. Items -27.2017 -28.9434 -30.9655 -68.3452 -102.901 -130.403
Income Available to Common Incl. Extra. Items -27.2017 -28.9434 -30.9655 -68.3452 -102.901 -130.403
Diluted Net Income -27.2017 -28.9434 -30.9655 -68.3452 -102.901 -130.403
Diluted Weighted Average Shares 19.1507 22.7646 26.8837 34.0203 37.2069 37.6186
Diluted EPS Excluding Extraordinary Items -1.4204 -1.27142 -1.15183 -2.00896 -2.76563 -3.46645
Dividends per Share - Common Stock Primary Issue 0
Diluted Normalized EPS -1.4204 -1.27142 -1.15183 -2.00896 -2.73211 -3.46645
Revenue 0 0
Q1 2021 Q2 2021 Q3 2021 Q4 2021 Q1 2022
Total revenue 0 0 0 0 0
Total Operating Expense 27.8441 30.8477 33.4071 32.608 38.2889
Selling/General/Admin. Expenses, Total 11.2484 16.3444 20.2269 18.8266 25.7037
Research & Development 16.5957 14.5033 13.1803 13.7815 12.5851
Operating Income -27.8441 -30.8477 -33.4071 -32.608 -38.2889
Interest Income (Expense), Net Non-Operating -1.41591 -1.43652 -1.47554 -1.3681 -1.34344
Net Income Before Taxes -29.26 -32.2842 -34.8827 -33.9761 -39.6323
Net Income After Taxes -29.26 -32.2842 -34.8827 -33.9761 -39.6323
Net Income Before Extra. Items -29.26 -32.2842 -34.8827 -33.9761 -39.6323
Net Income -29.26 -32.2842 -34.8827 -33.9761 -39.6323
Income Available to Common Excl. Extra. Items -29.26 -32.2842 -34.8827 -33.9761 -39.6323
Income Available to Common Incl. Extra. Items -29.26 -32.2842 -34.8827 -33.9761 -39.6323
Diluted Net Income -29.26 -32.2842 -34.8827 -33.9761 -39.6323
Diluted Weighted Average Shares 37.4295 37.5951 37.681 37.7662 38.3232
Diluted EPS Excluding Extraordinary Items -0.78174 -0.85874 -0.92574 -0.89965 -1.03416
Dividends per Share - Common Stock Primary Issue 0 0 0 0
Diluted Normalized EPS -0.78174 -0.85874 -0.92574 -0.89965 -1.03416
Unusual Expense (Income) 0 0
  • Annual
  • Quarterly
2016 2017 2018 2019 2020 2021
Total Current Assets 37.9991 35.2995 15.2151 220.379 184.025 86.5181
Cash and Short Term Investments 36.6185 34.0211 13.9687 219.966 183.876 86.4728
Cash & Equivalents 36.6185 34.0211
Prepaid Expenses 1.38056 1.27842 1.24636 0.4131 0.14837 0.04529
Total Assets 38.2126 35.5556 15.3793 220.55 186.134 87.7851
Property/Plant/Equipment, Total - Net 0.10073 0.06807 0.05183 0.03062 1.79212 0.94401
Other Long Term Assets, Total 0.11282 0.18795 0.11235 0.13988 0.31738 0.32291
Total Current Liabilities 7.17071 12.1753 10.8219 24.4947 23.4379 23.0652
Accounts Payable 4.08117 3.43546 3.68725 10.9433 13.504 13.1493
Accrued Expenses 2.82038 2.67953 3.8433 10.9491 9.93384 9.91586
Notes Payable/Short Term Debt 0 0 0 0 0 0
Current Port. of LT Debt/Capital Leases 0.26916 3.26935 3.29139 2.60229 0
Total Liabilities 16.6412 18.8383 14.4414 41.8274 72.3414 72.1547
Total Long Term Debt 9.47045 6.66301 3.61942 17.3326 48.3218 49.0895
Long Term Debt 9.47045 6.66301 3.61942 17.3326 48.3218 49.0895
Total Equity 21.5714 16.7172 0.93792 178.722 113.793 15.6304
Common Stock 0.00192 0.00255 0.00301 0.00369 0.00374 0.00378
Additional Paid-In Capital 69.211 93.2995 108.485 354.614 392.585 424.826
Retained Earnings (Accumulated Deficit) -47.6414 -76.5848 -107.55 -175.895 -278.796 -409.199
Total Liabilities & Shareholders’ Equity 38.2126 35.5556 15.3793 220.55 186.134 87.7851
Total Common Shares Outstanding 19.1584 25.493 30.0872 36.9332 37.3741 37.8168
Other Current Liabilities, Total 2.791 0
Cash 13.9687 219.966 183.876 86.4728
Other Liabilities, Total 0.58171 0
Mar 2021 Jun 2021 Sep 2021 Dec 2021 Mar 2022
Total Current Assets 165.035 141.655 115.024 86.5181 86.8299
Cash and Short Term Investments 164.66 141.219 114.623 86.4728 84.7078
Cash 164.66 141.219 114.623 86.4728
Prepaid Expenses 0.37531 0.4358 0.4013 0.04529 2.12214
Total Assets 166.904 143.265 116.599 87.7851 88.5603
Property/Plant/Equipment, Total - Net 1.55103 1.29248 1.25142 0.94401 1.40743
Other Long Term Assets, Total 0.31738 0.31738 0.32291 0.32291 0.32291
Total Current Liabilities 21.6828 22.8637 24.707 23.0652 24.5496
Accounts Payable 14.6217 11.612 13.3817 13.1493 12.5951
Accrued Expenses 7.06107 11.2517 11.3253 9.91586 11.9545
Notes Payable/Short Term Debt 0 0 0 0 0
Total Liabilities 70.6106 71.8281 73.8807 72.1547 73.8623
Total Long Term Debt 48.5979 48.8826 49.1737 49.0895 49.3127
Long Term Debt 48.5979 48.8826 49.1737 49.0895 49.3127
Other Liabilities, Total 0.32992 0.08186 0 0
Total Equity 96.2932 71.4366 42.7178 15.6304 14.698
Common Stock 0.00376 0.00377 0.00377 0.00378 0.00389
Additional Paid-In Capital 404.346 411.773 417.937 424.826 463.526
Retained Earnings (Accumulated Deficit) -308.056 -340.34 -375.223 -409.199 -448.831
Total Liabilities & Shareholders’ Equity 166.904 143.265 116.599 87.7851 88.5603
Total Common Shares Outstanding 37.5639 37.6489 37.6879 37.8168 38.8834
Cash & Equivalents 84.7078
  • Annual
  • Quarterly
2016 2017 2018 2019 2020 2021
Net income/Starting Line -27.2017 -28.9434 -30.9655 -68.3452 -102.901 -130.403
Cash From Operating Activities -21.2813 -26.4716 -30.0537 -46.3751 -78.4566 -108.226
Cash From Operating Activities 0.02048 0.04256 0.04894 0.03733 0.02386 0.07635
Non-Cash Items 2.10035 3.18873 -0.66039 6.76515 23.9992 22.9577
Changes in Working Capital 3.79952 -0.75955 1.52322 15.1676 0.42101 -0.85683
Cash From Investing Activities -0.10456 -0.0099 -0.0327 -0.01612 -0.04589 -0.30755
Capital Expenditures -0.10456 -0.0099 -0.0327 -0.01612 -0.04589 -0.30755
Cash From Financing Activities 9.9681 23.8842 10.034 252.389 42.4128 11.1297
Financing Cash Flow Items -0.06493 0 -0.026 0 -1.10261 -0.48505
Issuance (Retirement) of Stock, Net 0.03303 24.1619 13.3933 239.627 15.1754 11.6148
Issuance (Retirement) of Debt, Net 10 -0.27778 -3.33333 12.7611 28.34 0
Net Change in Cash -11.4178 -2.59737 -20.0524 205.997 -36.0897 -97.4036
Cash Interest Paid 1.28751 2.09729 4.62521
Mar 2021 Jun 2021 Sep 2021 Dec 2021 Mar 2022
Net income/Starting Line -29.26 -61.5442 -96.4269 -130.403 -39.6323
Cash From Operating Activities -27.2155 -52.609 -79.3852 -108.226 -32.653
Cash From Operating Activities 0.00833 0.01808 0.04531 0.07635 0.03664
Non-Cash Items 4.26996 10.2785 16.5674 22.9577 8.09654
Cash Interest Paid 1.14375 2.31292 3.48208 4.62521 1.11875
Changes in Working Capital -2.2338 -1.36147 0.42894 -0.85683 -1.15384
Cash From Investing Activities -0.03 -0.04887 -0.30755 -0.30755 -0.21374
Capital Expenditures -0.03 -0.04887 -0.30755 -0.30755 -0.21374
Cash From Financing Activities 8.02916 10.0006 10.4392 11.1297 31.1016
Issuance (Retirement) of Stock, Net 8.02916 10.0846 10.5232 11.6148 31.1902
Net Change in Cash -19.2163 -42.6574 -69.2536 -97.4036 -1.76507
Financing Cash Flow Items -0.08401 -0.08401 -0.48505 -0.08859
Issuance (Retirement) of Debt, Net 0 0
Investor Name Investor Type Percent Outstanding Shares Held Shares change Holdings Date Turnover Rating
Antecip Capital, L.L.C. Corporation 16.9126 7344500 0 2022-04-11 LOW
The Vanguard Group, Inc. Investment Advisor/Hedge Fund 7.1523 3105980 310084 2022-09-30 LOW
PFM Health Sciences, LP Hedge Fund 4.9733 2159733 500000 2022-10-14 LOW
BlackRock Institutional Trust Company, N.A. Investment Advisor 4.5333 1968654 -44136 2022-09-30 LOW
Fairmount Funds Management LLC Hedge Fund 4.3675 1896647 954076 2022-09-30 MED
RTW Investments L.P. Investment Advisor/Hedge Fund 4.3342 1882164 263345 2022-09-30 LOW
Avidity Partners Management LP Hedge Fund 3.543 1538600 1538600 2022-09-30 MED
Alethea Capital Management, LLC Investment Advisor 1.8152 788263 -1550 2022-09-30 MED
State Street Global Advisors (US) Investment Advisor/Hedge Fund 1.638 711332 -141651 2022-09-30 LOW
Nuveen LLC Pension Fund 1.597 693524 -77473 2022-09-30 LOW
Point72 Asset Management, L.P. Hedge Fund 1.4229 617900 576125 2022-09-30 HIGH
Geode Capital Management, L.L.C. Investment Advisor/Hedge Fund 1.2955 562589 30837 2022-09-30 LOW
Citadel Advisors LLC Hedge Fund 1.2235 531337 80342 2022-09-30 HIGH
Paradigm BioCapital Advisors LP Investment Advisor 1.1976 520080 520080 2022-09-30 HIGH
Bellevue Asset Management AG Investment Advisor 1.1434 496524 -320617 2022-09-30 LOW
Coleman (Mark H) Individual Investor 1.0305 447525 17501 2023-01-03 LOW
Goldman Sachs & Company, Inc. Research Firm 0.9373 407038 69490 2022-09-30 MED
Cannell & Co. Investment Advisor 0.8521 370020 320680 2022-12-31 LOW
Millennium Management LLC Hedge Fund 0.8086 351140 3689 2022-09-30 HIGH
Fidelity Management & Research Company LLC Investment Advisor 0.8034 348896 112905 2022-09-30 LOW

Mengapa memilih Capital.com? Biarlah angka kami yang berbicara.

Capital.com Group
+500000+

Trader

93000+

Klien aktif per bulan

$57000000+

Volume investasi per bulan

$31000000+

Penarikan tiap bulan

Trading calculator

Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).

Trade commission
0
  • 1:1
  • 2:1
  • 5:1
  • 10:1
  • 20:1
Leverage
20:1
  • 20
  • 100
  • 500
  • 1000
  • 10000
Investment
Trade size (Leverage x Investement):
Open

Close

Short Long
Industry: Bio Therapeutic Drugs

22 Cortlandt Street, 16Th Floor
NEW YORK
NEW YORK 10007
US

Income Statement

  • Annual
  • Quarterly

People also watch

Natural Gas

2.57 Price
-2.100% 1D Chg, %
Biaya inap posisi Long -0.1071%
Biaya inap posisi short 0.0755%
Waktu biaya inap 22:00 (UTC)
Spread 0.005

BTC/USD

23,149.00 Price
-0.330% 1D Chg, %
Biaya inap posisi Long -0.0500%
Biaya inap posisi short 0.0140%
Waktu biaya inap 22:00 (UTC)
Spread 60.00

Oil - Crude

77.84 Price
+0.090% 1D Chg, %
Biaya inap posisi Long -0.0218%
Biaya inap posisi short 0.0068%
Waktu biaya inap 22:00 (UTC)
Spread 0.03

US100

12,699.00 Price
-0.060% 1D Chg, %
Biaya inap posisi Long -0.0186%
Biaya inap posisi short 0.0075%
Waktu biaya inap 22:00 (UTC)
Spread 1.8

Masih mencari broker yang bisa Anda percayai?

Bergabung dengan 500.000+ trader di seluruh dunia yang telah memilih trading bersama Capital.com

1. Buat & verifikasi akun Anda 2. Lakukan deposit 3. Temukan trading Anda